Global Cord Blood Corporation Stock Deutsche Boerse AG
Equities
6CB
KYG393421030
Healthcare Facilities & Services
Sales 2021 | 1.16B 160M 148M 219M | Sales 2022 | 1.24B 172M 158M 235M | Capitalization | 2.97B 410M 378M 561M |
---|---|---|---|---|---|
Net income 2021 | 508M 70.18M 64.63M 96.04M | Net income 2022 | 501M 69.21M 63.73M 94.71M | EV / Sales 2021 | -2.13 x |
Net cash position 2021 | 6.07B 839M 773M 1.15B | Net cash position 2022 | 6.66B 920M 847M 1.26B | EV / Sales 2022 | -2.97 x |
P/E ratio 2021 |
7.1
x | P/E ratio 2022 |
5.93
x | Employees | 1,202 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 38.41% |
Managers | Title | Age | Since |
---|---|---|---|
Ting Zheng
CEO | Chief Executive Officer | 52 | 08-12-31 |
Bing Chuen Chen
DFI | Director of Finance/CFO | 48 | 08-12-31 |
Xin Xu
CTO | Chief Tech/Sci/R&D Officer | 70 | 04-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer J. Weng
BRD | Director/Board Member | 56 | 08-12-31 |
Ting Zheng
CEO | Chief Executive Officer | 52 | 08-12-31 |
Director/Board Member | 56 | 08-12-31 |
1st Jan change | Capi. | |
---|---|---|
+21.78% | 87.14B | |
-23.80% | 75.59B | |
+1.76% | 26.78B | |
+4.28% | 17.89B | |
-14.09% | 16.44B | |
+2.09% | 15.68B | |
+72.84% | 13.3B | |
+76.31% | 13.06B | |
+3.61% | 12.54B |